Trademark: 79366890
Word
FOLDIKINE
Status Date
Tuesday, March 26, 2024
Registration Number
7334166
Registration Date
Tuesday, March 26, 2024
Filing Date
Wednesday, December 7, 2022
Published for Opposition
Tuesday, January 9, 2024
5 Pharmaceutical preparations for the treatment of immune-mediated diseases; veterinary preparations for the treatment of immune-mediated diseases; biological preparations for medical use for the treatment of immune-mediated diseases; biological preparations for veterinary purposes for the treatment of immune-mediated diseases; immunomodulators; immunosuppressants; immunostimulants; growth factors, namely, cell growth media for growing cells for medical or clinical use; cell survival factors, namely cell growth media for growing cells for medical or clinical use; pharmaceutical and veterinary preparations for regulating the immune system; pharmaceutical and veterinary preparations for the treatment and/or prevention of diseases and disorders of the immune system or those affecting the immune system; regulatory proteins for medical and veterinary use in the nature of protein arrays for medical use and medical diagnosis purposes
1 Protein in raw material form for scientific and medical research; proteins for use in science; proteins for use in industry; proteins for use in the manufacture of cosmetics; biological preparations for industry and science; biological preparations for use in the manufacture of cosmetics; immunomodulatory biological molecules and chimeras thereof for scientific use, other than for medical or veterinary use; immunomodulatory biological molecules and chimeras thereof for industrial use, other than for medical or veterinary use; immunomodulatory biological molecules and chimeras thereof for use in the manufacture of cosmetics; immunomodulatory biological molecules and chimeras thereof for use in laboratories, other than for medical or veterinary use; culture media for microbiology for scientific and research use; culture media of eukaryotic cells, in particular, immune, lymphoid and myeloid cells for scientific and research use
42 Scientific and technological services, namely, scientific research ; research and development of products; design and development of biological, pharmaceutical and veterinary products; medical, pharmacological and veterinary research services; research related to molecular science; research and development services in immunology; research and development services in the field of immunohistology; research and development services with respect to immunomodulatory molecules; laboratory research services in relation to the production of immunomodulatory biological molecules and chimeras thereof; software design and development; information, advisory, and consultancy relating to the aforesaid services
Sep 13, 2023
Assigned To Examiner
Apr 6, 2023
Sn Assigned For Sect 66a Appl From Ib
Apr 10, 2023
New Application Office Supplied Data Entered
Apr 14, 2023
Application Filing Receipt Mailed
Sep 20, 2023
Non-Final Action Written
Sep 21, 2023
Non-Final Action (Ib Refusal) Prepared For Review
Oct 3, 2023
Refusal Processed By Mpu
Oct 3, 2023
Non-Final Action Mailed - Refusal Sent To Ib
Oct 25, 2023
Refusal Processed By Ib
Nov 14, 2023
Teas Response To Office Action Received
Nov 14, 2023
Correspondence Received In Law Office
Nov 14, 2023
Teas/Email Correspondence Entered
Nov 29, 2023
Approved For Pub - Principal Register
Dec 20, 2023
Notification Of Possible Opposition Sent To Ib
Dec 20, 2023
Notification Of Notice Of Publication E-Mailed
Dec 20, 2023
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Jan 9, 2024
Published For Opposition
Jan 9, 2024
Official Gazette Publication Confirmation E-Mailed
Mar 26, 2024
Registered-Principal Register
Mar 26, 2024
Notice Of Registration Confirmation Emailed
Jun 27, 2024
Final Disposition Notice Created, To Be Sent To Ib
Jan 8, 2024
Notification Processed By Ib
Trademark Alertz updated from USPTO on 2030-01-24
